“…Pharmacokinetic models are a common method of extracting quantitative measures of perfusion from the contrast enhancement curves of DCE-MRI volumes ( Tofts et al., 1999 ). However, these measures depend on the selection of the compartment model, which in turn depends on the tissue characteristics, as well as the choice or measurement of an arterial input function ( Irving et al., 2013 ). Tumour heterogeneity means that a single model is rarely appropriate for the whole tumour and surrounding region ( Kallehauge et al., 2014 ).…”